- Home
- HUM vs DD Comparison
HUM vs DD Comparison
Compare HUM & DD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUM | DD |
|---|---|---|
| Founded | 1961 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.5B | 20.2B |
| IPO Year | 2002 | 2016 |
Fundamental Metrics
Financial Performance| Metric | HUM | DD |
|---|---|---|
| Price | $193.51 | $47.11 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 20 | 14 |
| Target Price | ★ $237.65 | $62.07 |
| AVG Volume (30 Days) | 1.5M | ★ 2.9M |
| Earning Date | 04-29-2026 | 05-01-2026 |
| Dividend Yield | ★ 1.79% | 1.69% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 9.84 | N/A |
| Revenue | ★ $129,664,000,000.00 | $20,397,000,000.00 |
| Revenue This Year | $25.34 | $6.91 |
| Revenue Next Year | $6.11 | $3.85 |
| P/E Ratio | $20.15 | ★ N/A |
| Revenue Growth | ★ 10.11 | N/A |
| 52 Week Low | $163.11 | $33.34 |
| 52 Week High | $315.35 | $83.40 |
Technical Indicators
Market Signals| Indicator | HUM | DD |
|---|---|---|
| Relative Strength Index (RSI) | 59.57 | 55.37 |
| Support Level | $186.00 | $42.54 |
| Resistance Level | $285.02 | $52.66 |
| Average True Range (ATR) | 6.88 | 1.14 |
| MACD | 3.95 | 0.35 |
| Stochastic Oscillator | 71.26 | 78.56 |
Price Performance
Historical ComparisonAbout HUM Humana Inc.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
About DD DuPont de Nemours Inc.
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the healthcare, water, construction, automotive, aerospace, and printing and packaging industries. Healthcare and water will generate the majority of profits.